PRECAMANCT03144648
PRECAMA: Molecular Subtypes of Premenopausal Breast Cancer in Latin American Women
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 12 words Show 4 more changesShow less
- Trial completed
- Final enrollment: 1500 participants (planned 3000)
- Site details revised at 13 of 13 sites
- Study description expanded, about 4 words
- Minor Site details revised at 2 of 13 sitesv5
- Notable Primary and study completion dates: Dec 30, 2022 to Dec 30, 2025
- Study sites: 8 to 13
- Collaborators revised (5)
- Notable Primary and study completion dates: Dec 30, 2020 to Dec 30, 2022v3
- Minor Study sites: 6 to 8v2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Arms and interventions
Incident primary invasive breast cancer cases aged 20-45 years are recruited from major cancer hospitals in five Latin American cities (Barretos, Mexico City, San Jose, Medellin, and Santiago) prior to any treatments. For each subject, complete questionnaire data on socio-demographic factors, health and reproductive history, early risk factors, physical activity, diet, environmental risk factors, ethnicity, and family history of cancer are collected. Validated and standardized food frequency questionnaires are administered to gather information on diet. Anthropometry is measured according to standardized protocols. Blood and urine samples are also collected for biomarker analyses. Highly standardized immunohistochemical and molecular analyses are performed to identify cancer subtypes
Women with no cancer recruited from the population residing in the same cities for at least 3 years and matched to cases on age (+/- 5 years) and health care institution. For each subject, complete questionnaire data on socio-demographic factors, health and reproductive history, early risk factors, physical activity, diet, occupation, environmental risk factors, ethnicity, and family history of cancer are collected. Validated and standardized food frequency questionnaires are administered to gather information on diet. Anthropometry is measured according to standardized protocols. Blood and urine samples are also collected for biomarker analyses.
Other: lifestyle
Sites
13 sites in 5 countries
Colombia 7, Chile 3, Brazil 1, Costa Rica 1, Mexico 1